You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0185 Comparison of tofacitinib safety and efficacy in rheumatoid arthritis patients with inadequate response to conventional synthetic dmards, or to one or more biological dmards

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - non biologic treatment
THU0185 Comparison of tofacitinib safety and efficacy in rheumatoid arthritis patients with inadequate response to conventional synthetic dmards, or to one or more biological dmards
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20171201
Jul 2017800
Aug 20173803
Sep 20171205
Oct 20171202
Nov 2017800
Dec 20173202
Jan 20183203
Feb 20184202
Mar 20183400
Apr 20183401
May 20184001
Jun 20182000
Jul 20181800
Aug 20181601
Sep 2018800
Oct 2018002
Nov 20181004
Dec 2018801
Jan 20191002
Feb 2019200
Mar 2019603
Apr 2019003
May 2019203
Jun 2019402
Jul 20192007
Aug 20191406
Sep 2019401
Oct 2019603
Nov 2019401
Dec 20191403
Jan 20201203
Feb 2020601
Mar 2020401
Apr 2020404
May 20201806
Jun 2020603
Jul 2020801
Aug 2020803
Sep 20201600
Oct 2020604
Nov 20201404
Dec 2020402
Feb 2021202
Mar 2021602
Apr 2021404
May 2021207
Jun 2021003
Jul 2021007
Aug 2021102
Sep 2021003
Oct 202114017
Nov 2021608
Dec 20211401
Jan 20222000
Feb 2022301
Mar 20221905
Apr 2022703
May 20221707
Jun 2022803
Jul 20221801
Aug 20221409
Sep 2022407
Oct 2022403
Nov 2022907
Dec 20221201
Jan 20231003
Feb 2023401
Mar 20231201
Apr 2023004
May 2023207
Jun 2023001
Jul 2023203
Aug 2023301
Sep 2023201
Oct 20231803
Nov 2023202
Dec 20231401
Jan 2024202
Feb 2024502
Mar 20248024
Total8440253